To analyze the prevalence of cardiovascular disease (CVD) and osteoporosis in patients treated with androgen deprivation therapy (ADT) for prostate cancer (PCa) but not adherent to European Association of Urology (EAU) guidelines.
Prevalence of Cardiovascular Disease and Osteoporosis During Androgen Deprivation Therapy Prescription Discordant to EAU Guidelines: Results From a Multicenter, Cross-sectional Analysis From the CHOsIng Treatment for Prostate canCEr (CHOICE) Study
RICARDI, Umberto;TERRONE, Carlo;GONTERO, Paolo;
2016-01-01
Abstract
To analyze the prevalence of cardiovascular disease (CVD) and osteoporosis in patients treated with androgen deprivation therapy (ADT) for prostate cancer (PCa) but not adherent to European Association of Urology (EAU) guidelines.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Prevalence of cardiovascular disease.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
382.24 kB
Formato
Adobe PDF
|
382.24 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
